Stockholm Convention Secretariat opens comment period on draft review of specific exemption for PFOI→PFOB (pharmaceuticals)

The Stockholm Convention Secretariat published an invitation for Parties and stakeholders to submit comments on a draft report reviewing the specific exemption for the use of perfluorooctyl iodide (PFOI) to produce perfluorooctyl bromide (PFOB) for pharmaceutical products. This consultation may inform whether the exemption is continued, modified, or allowed to expire, which is relevant for pharmaceutical supply chains relying on this specific exemption pathway.